Journal of Biological Response Modifiers
Monoclonal Antibodies to Human Melanoma
The Rationale for and Design of a Screening Procedure for the Assessment of Biological Response Modifiers for Cancer Treatment
Inhibition of Lung Metastases by Liposomal Immunotherapy in a Murine Fibrosarcoma Model
Phase I Trials of Thymosin Fraction 5 and Thymosin α1
Efficacy of Liposomes Containing a Lipophilic Muramyl Dipeptide Derivative for Activating the Tumoricidal Properties of Alveolar Macrophages In Vivo
Active Specific Intralymphatic Immunotherapy in Metastatic Malignant Melanoma
Induction of a Lymphohemopoietic Stimulating Factor in the Serum of Thiabendazole-Treated Mice
Biological Response Modifiers Program